FierceBiotechOriginal article
{"a":[{"_":"Craif raises $33M to boost work on its urine test for cancer ","$":{"href":"/medtech/craif-raises-33m-boost-work-its-urine-test-cancer","hreflang":"en"}}]}
urine test for cancerPositive
AI Analysis
Summary
Craif raised $33 million in Series D funding to advance its AI-powered urine test for cancer detection, bringing total capital raised to $88 million. The company also announced a new executive addition.
Importance:4/10
Sentiment:
0.60
fundingSeries Dcancer diagnosticsAI/machine learningurine test
Read the original article
Published by FierceBiotech on August 18, 2026 8:14 AM
